No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs8100675 |
chr19:40044635-40044636 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs56306459 |
chr19:40044647-40044648 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs182985684 |
chr19:40044648-40044649 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs112132529 |
chr19:40044653-40044654 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs569010671 |
chr19:40044654-40044655 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs571505608 |
chr19:40044657-40044658 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs75855570 |
chr19:40044667-40044668 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs75663148 |
chr19:40044668-40044669 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs539048671 |
chr19:40044717-40044718 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs188432690 |
chr19:40044729-40044730 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs557871996 |
chr19:40044735-40044736 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs555737959 |
chr19:40044760-40044761 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs116653334 |
chr19:40044787-40044788 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs59363865 |
chr19:40044790-40044791 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs114699203 |
chr19:40044801-40044802 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs201961352 |
chr19:40044809-40044810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs112230938 |
chr19:40044832-40044833 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs544081265 |
chr19:40044839-40044840 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs565592222 |
chr19:40044871-40044872 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs546589911 |
chr19:40044901-40044902 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs369758944 |
chr19:40044909-40044910 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs576728969 |
chr19:40044957-40044958 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs541055749 |
chr19:40044978-40044979 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs34986409 |
chr19:40044990-40044991 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs373280053 |
chr19:40044999-40045000 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs74345413 |
chr19:40045000-40045001 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs547971274 |
chr19:40045038-40045039 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs142038976 |
chr19:40045061-40045062 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs530624894 |
chr19:40045171-40045172 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs112512968 |
chr19:40045174-40045175 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs12608773 |
chr19:40045197-40045198 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs550303010 |
chr19:40045216-40045217 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs191223038 |
chr19:40045272-40045273 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs538644334 |
chr19:40045298-40045299 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs183731122 |
chr19:40045321-40045322 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs188251528 |
chr19:40045331-40045332 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs151143837 |
chr19:40045335-40045336 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs16973498 |
chr19:40045336-40045337 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs192369377 |
chr19:40045357-40045358 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs537655869 |
chr19:40045539-40045540 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs558971455 |
chr19:40045547-40045548 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs561501620 |
chr19:40045564-40045565 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs577494637 |
chr19:40045578-40045579 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs185689839 |
chr19:40045608-40045609 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs552971510 |
chr19:40045612-40045613 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs79752981 |
chr19:40045622-40045623 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs201508896 |
chr19:40045636-40045637 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs541479989 |
chr19:40045650-40045651 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs80077727 |
chr19:40045676-40045677 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs530588383 |
chr19:40045679-40045680 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|